CAS No. 2378114-72-6
Batch:
Purity:99.94
Chemical Structure
Check the
Lanreotide acetate
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | |
|---|---|---|
| CAS Number | 2378114-72-6 | |
| Molecular Formula |
C56H73N11O12S2 |
|
| Molecular Weight (MW) | 1156.38 | |
| SMILES | CC(C)C1NC(=O)C(CCCCN)NC(=O)C(CC2=C[NH]C3=C2C=CC=C3)NC(=O)C(CC4=CC=C(O)C=C4)NC(=O)C(CSSCC(NC1=O)C(=O)NC(C(C)O)C(N)=O)NC(=O)C(N)CC5=CC6=CC=CC=C6C=C5.CC(O)=O | |
| InChIKey | DEXPIBGCLCPUHE-UISHROKMSA-N |
Lanreotide acetate is a synthetic somatostatin analog that acts as a somatostatin receptor agonist, primarily targeting somatostatin receptor subtypes 2 and 5 (SSTR2 and SSTR5). Upon binding to these receptors, it suppresses intracellular cyclic AMP production, leading to the inhibition of growth hormone secretion and attenuation of cell proliferation. Lanreotide also exerts direct antitumoral effects by promoting cell cycle arrest and triggering apoptosis in somatostatin receptor-expressing tumor cells. [1][2]
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| Water | 23 mg/mL |
| DMSO |
100 mg/mL
(86.47 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | 25 mg/mL |
| Ethanol | 25 mg/mL |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Lanreotide acetate Clinical Trials
- Lanreotide acetate Solubility in DMSO
- Lanreotide acetate Stock Solution
- Lanreotide acetate Storage
- Lanreotide acetate Stability
- Lanreotide acetate Molecular Weight
- Lanreotide acetate SMILES
- Lanreotide acetate Chemical Structure (2D and 3D)
- Lanreotide acetate SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.